Project Grant R34DA030731

Federal Project Grant Award Summary Massachusetts General Hospital received a $740,451 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded May 1, 2026, with completion targeted for February 28, 2031. The award supports a randomized controlled trial evaluating the effectiveness of Community Health Worker (CHW) support delivered by existing Medicaid-funded behavioral health staff for tobacco use disorder (TUD)...

Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $742,500 Project Grant (R34) to Massachusetts General Hospital on July 15, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279). This three-year pilot study, concluding June 30, 2028, will develop and test a peer recovery coaching intervention designed to promote tobacco abstinence in individuals with concurrent opioid use disorder and tobacco use disorder (MOUD-TUD). The project will adapt an...

Federal Cooperative Agreement Summary The National Institute on Drug Abuse (NIDA) awarded a $5.73 million Cooperative Agreement to the University of Southern California on July 15, 2025, for a multi-site randomized clinical trial investigating the efficacy of tirzepatide, a dual glucagon-like-peptide 1/gastric inhibitory peptide (GLP-1/GIP) receptor agonist, for smoking cessation. The 24-week trial will evaluate whether this medication—which has demonstrated superior weight loss efficacy...

Federal Grant Award Summary The National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded the University of Oklahoma Health Sciences Center a Project Grant of $200,951 effective May 1, 2026, through April 30, 2031. This award supports research and training aimed at developing a social media-based vaping cessation intervention for young adults that integrates peer mentoring components. The project, titled "Integrating Peer Mentoring...

This Project Grant award of $320,000 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to develop a smoking and vaping cessation treatment based on the drug candidate cytisine. The goal is to explore the feasibility of delivering cytisine through electronic vape administration (EVA) to help stabilize dopamine release and reduce nicotine self-administration in a mouse model of nicotine addiction. Key activities include...

Grant Award Summary Duke University received a $906,306 Project Grant from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) awarded September 11, 2025, with completion targeted for August 31, 2028. The award funds development and testing of a telehealth-delivered, cue-based treatment intervention designed to promote smoking cessation among people who smoke lightly (PSLI), defined as those smoking 10 cigarettes per day or fewer. Building...

Summary San Diego State University Research Foundation received a $213,381 K23 Mentored Patient-Oriented Research Career Development Award from the National Institute of Mental Health under the Mental Health Research Grants program (CFDA 93.242), effective August 1, 2025 through July 31, 2030. This award funds advanced training and career development for the principal investigator to establish an independent research program addressing mental health service disparities among youth from...

Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded The Trustees of Columbia University in the City of New York $581,543 through its Drug Use and Addiction Research Programs (CFDA 93.279) on April 15, 2026, to conduct a clinical research project evaluating the Sense2Quit mobile health application for smoking cessation among people with HIV (PWH). The award supports an R01 Research Project Grant with a performance period extending through February 28, 2031. The primary...

Federal Project Grant Award Summary Oregon Health & Science University (OHSU) received a $2.44 million Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) awarded July 15, 2025, with completion targeted for March 31, 2030. The TEAM-UP (Tobacco Treatment Navigators Uniting with Primary Care) initiative addresses tobacco use disorder, which accounts for nearly 500,000 premature deaths annually in the United States. The...

Federal Project Grant Award Summary The National Cancer Institute (NCI) awarded the University of Pennsylvania a Project Grant of $663,554 under the Cancer Cause and Prevention Research program (CFDA 93.393) on August 18, 2025, with an ultimate completion date of July 31, 2030. This research project, titled "Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People Unmotivated to Quit," will develop and test harm reduction product sampling as a pragmatic...